Diabetes falls under the category of chronic diseases. In other words, the patient suffering from diabetes cannot obtain respite all through their life. More than 70% of the affected population lives in the low and middle income countries, with China and India standing as the topmost contributors. WHO has predicted that China is expected to lose around $557 billion in national income due to diabetes and its adverse effects between 2005 and 2015; whereas that for Russia, India, and Brazil will be around $302 billion, $236 billion, and $49 billion respectively. Low diagnosis rate ranging from 35% from 55%, poor health infrastructure, and lack of reimbursement have worsened the situation in these countries.

Economic burden of diabetes is very high on the healthcare system. Global share of diabetes care expenses is about 11.6% of the total healthcare expenditure. The annual diabetes expenditure was at $376 billion in 2010, with per capita expenditure at $703. Although the diabetes care expenditure is the highest in the U.S., the BRIC region represents the most lucrative market with a CAGR of 17% during 2010-2015; which is almost double as compared to the global market for diabetes care devices.

Much of the growth in the BRIC diabetes care devices market can be attributed to sudden increase in the diagnosis rate of the diabetes cases, especially in China and India. China and India have around half of the diabetic population of the world. Lack of awareness is the major concern, as about 45% - 55% affected cases remain undiagnosed. This low diagnosis rate and the huge patient pool are the leading factors of high market growth in BRIC economies.

Large untapped population, increased initiatives taken by the government, active participation of the companies to increase the awareness will set the stage of high growth diabetes care devices market in BRIC countries. The market was approximately worth $489.7 million in 2010 and is expected to grow at a CAGR of 17% from 2010 to 2015. SMBG is the highest selling product and the leading contributor in the market growth. Advancement in new technologies such as CGM will further boost the market sentiments.

The BRIC diabetes care market carries high potential as the penetration level of the devices is very low. Various initiatives have been taken by the government and the companies to apprise the people about the disease and promote the adoption of the devices. Companies are strongly focusing on the new product innovations such as CGM to improve the quality of life of diabetes patients. Though the reimbursement issues are prevalent, the market is expected to increase exponentially. SMBG device will remain the most popular device due to its low cost and comfort in use.

Scope of the report

This market research report analyzes the diabetes care devices market in Brazil, Russia, India, and China (BRIC) from 2010 to 2015. The scope of the report is limited to three devices- insulin pumps, self monitoring of blood glucose, and continuous glucose monitoring. The market structure is designed on the basis of secondary research on the most preferred systems available in the market. This structure is cross validated through primaries conducted with various industry players. The market forecasts are based on data from primary and secondary research. Further, the market revenues for each segment are based on the market penetration rates. The market research report is made using primary research data as well as information sourced from proprietary databases, secondary research, and our in house team of industry experts.

For the purpose of market estimations, penetration rates are calculated based on the per capita diabetes care expenditure in various geographies.

TABLE OF CONTENTS   

EXECUTIVE SUMMARY   
  OBJECTIVE 
  MARKET SCENARIO 
  COMPETITIVE LANDSCAPE 
  CONCLUSION 
 
1 INTRODUCTION 
  1.1 KEY TAKE-AWAYS 
  1.2 REPORT DESCRIPTION 
  1.3 MARKETS COVERED 
  1.4 STAKEHOLDERS 
  1.5 RESEARCH METHODOLOGY 
 
2 SUMMARY 
 
3 MARKET OVERVIEW 
  3.1 INTRODUCTION 
  3.2 HIGH GLOBAL POPULATION OF DIABETICS 
  3.3 MARKET METRICS 
      3.3.1 MARKET DEFINITIONS 
  3.4 STRATEGIC CONCLUSIONS 

4 DIABETES CARE DEVICES MARKET – BRAZIL    
  4.1 INTRODUCTION 
  4.2 MARKET OVERVIEW 
  4.3 MARKET SIZE 
  4.4 DRIVERS 
      4.4.1 GOVERNMENT INITIATIVES 
      4.4.2 EATING HABITS MAKING CITIZENS DIABETES PRONE 
      4.4.3 INCREASING OBESITY 
  4.5 RESTRAINTS 
    4.5.1 ILLITERACY REGARDING USE OF DIABETES CARE DEVICES 
    4.5.2 LACK OF AWARENESS OF DISEASE AND ITS COMPLICATIONS 
    4.5.3 GEOGRAPHICAL LIMITATIONS 
    4.5.4 REGISTRATION PROCESS OF MEDICAL DEVICES 
  4.6 COMPETITIVE ANALYSIS 
  4.7 INSULIN PUMPS 
      4.7.1 CURRENT MARKET SIZE 
      4.7.2 COMPETITIVE ANALYSIS 
      4.7.3 MARKET TRENDS 
  4.8  SELF MONITORING BLOOD GLUCOSE 
      4.8.1 CURRENT MARKET SIZE 
      4.8.2 COMPETITIVE ANALYSIS 
      4.8.3 MARKET TRENDS 
  4.9  CONTINUOUS GLUCOSE MONITORING 
      4.9.1 CURRENT MARKET SIZE 
      4.9.2 COMPETITIVE ANALYSIS 
      4.9.3 MARKET TRENDS 
 
5 DIABETES CARE DEVICES MARKET – RUSSIA 
  5.1 INTRODUCTION 
  5.2 MARKET OVERVIEW 
  5.3 MARKET SIZE 
  5.4 DRIVERS 
      5.4.1 INCREASING DIABETIC POPULATION 
      5.4.2 GROWING AWARENESS 
      5.4.3 GOVERNMENT INITIATIVES 
  5.5 RESTRAINTS 
      5.5.1 INCONSISTENT REIMBURSEMENT 
      5.5.2 HIGH COST DEVICES 
      5.5.3 REGISTRATION PROCESS FOR MEDICAL DEVICES 
  5.6 COMPETITIVE ANALYSIS 
  5.7 INSULIN PUMPS 
      5.7.1 CURRENT MARKET SIZE 
      5.7.2 COMPETITIVE ANALYSIS 
      5.7.3 MARKET TRENDS 
  5.8 SELF MONITORING BLOOD GLUCOSE 
      5.8.1 CURRENT MARKET SIZE 
      5.8.2 COMPETITIVE LANDSCAPE 
      5.8.3 MARKET TRENDS 
  5.9 CONTINUOUS GLUCOSE MONITORING 
      5.9.1 CURRENT MARKET SIZE 
      5.9.2 COMPETITIVE LANDSCAPE 
      5.9.3 MARKET TRENDS 
 
6 DIABETES CARE DEVICES MARKET – INDIA 
  6.1 INTRODUCTION 
  6.2 MARKET OVERVIEW 
  6.3 MARKET SIZE 
  6.4 DRIVERS 
      6.4.1 HIGH DIABETIC POPULATION 
      6.4.2 USE OF SUPPORT TECHNOLOGIES IMPROVING ACCESS TO PATIENTS 
      6.4.3 DECREASING MEAN AGE OF DIABETICS IN INDIA 
  6.5 RESTRAINTS 
      6.5.1 LACK OF AWARENESS 
      6.5.2 HIGH COST OF DEVICES 
      6.5.3 DEVELOPMENT OF ALTERNATIVE SOLUTIONS 
      6.5.4 LACK OF REIMBURSEMENT 
  6.6 COMPETITIVE ANALYSIS 
  6.7 INSULIN PUMPS 
      6.7.1 CURRENT MARKET SIZE 
      6.7.2 COMPETITIVE ANALYSIS 
      6.7.3 MARKET TRENDS 
  6.8 SELF MONITORING BLOOD GLUCOSE 
      6.8.1 CURRENT MARKET SIZE 
      6.8.2 COMPETITIVE ANALYSIS 
      6.8.3 MARKET TRENDS 
  6.9 CONTINUOUS GLUCOSE MONITORING 
      6.9.1 CURRENT MARKET SIZE 
      6.9.2 COMPETITIVE ANALYSIS 
      6.9.3 MARKET TRENDS 
 
7 DIABETES CARE DEVICES MARKET – CHINA 
  7.1 INTRODUCTION 
  7.2 MARKET OVERVIEW 
  7.3 MARKET SIZE 
  7.4 DRIVERS 
      7.4.1 HIGH DIABETIC POPULATION 
      7.4.2 AGEING POPULATION 
      7.4.3 ECONOMIC GROWTH OF CHINA 
      7.4.4 GOVERNMENT INITIATIVE TOWARDS HEALTHCARE 
  7.5 RESTRAINTS 
      7.5.1 TRADITIONAL CHINESE MEDICINES 
      7.5.2 REIMBURSEMENT AND REGULATORY ISSUES 
      7.5.3 LOW LEVEL OF AWARENESS 
  7.6 COMPETITIVE LANDSCAPE 
  7.7 INSULIN PUMPS 
      7.7.1 CURRENT MARKET SIZE 
      7.7.2 COMPETITIVE ANALYSIS 
      7.7.3 MARKET TRENDS 
  7.8 SELF MONITORING BLOOD GLUCOSE 
      7.8.1 CURRENT MARKET SIZE 
      7.8.2 COMPETITIVE ANALYSIS 
      7.8.3 MARKET TRENDS 
  7.9 CONTINUOUS GLUCOSE MONITORING 
      7.9.1 CURRENT MARKET SIZE 
      7.9.2 COMPETITIVE ANALYSIS 
      7.9.3 MARKET TRENDS 
 
8 COMPETITIVE LANDSCAPE 
 
9 COMPANY PROFILES 
  9.1 ABBOTT LABORATORIES 
      9.1.1 Overview 
      9.1.2 Primary business 
      9.1.3 Financials 
      9.1.4 Strategy 
      9.1.5 Developments 
  9.2 ACON LABORATORIES 
      9.2.1 Overview 
      9.2.2 Primary business 
      9.2.3 Strategy 
      9.2.4 Developments 
  9.3 ARKRAY INC. 
      9.3.1 Overview 
      9.3.2 Primary business 
      9.3.3 Strategy 
      9.3.4 Developments 
  9.4 B. BRAUN MELSUNGEN AG 
      9.4.1 Overview 
      9.4.2 Primary business 
      9.4.3 Financials 
      9.4.4 Strategy 
      9.4.5 Developments 
  9.5 BAYER HEALTHCARE AG 
      9.5.1 Overview 
      9.5.2 Primary business 
      9.5.3 Financials 
      9.5.4 Strategy 
      9.5.5 Developments 
  9.6 BECTON, DICKINSON AND COMPANY 
      9.6.1 Overview 
      9.6.2 Primary business 
      9.6.3 Financials 
      9.6.4 Strategy 
      9.6.5 Developments 
  9.7 BIOMERICA, INC. 
      9.7.1 Overview 
      9.7.2 Primary business 
      9.7.3 Financials 
      9.7.4 Strategy 
      9.7.5 Developments 
  9.8 EXCOM, INC. 
      9.8.1 Overview 
      9.8.2 Primary business 
      9.8.3 Financials 
      9.8.4 Strategy 
      9.8.5 Developments 
  9.9 JOHNSON & JOHNSON 
      9.9.1 Overview 
      9.9.2 Products & services 
      9.9.3 Financials 
      9.9.4 Strategy 
      9.9.5 Developments 
  9.10 SPRING HEALTH SOLUTIONS LTD 
      9.10.1 Overview 
      9.10.2 Primary business 
      9.10.3 Strategy 
      9.10.4 Developments 
  9.11 NOVO NORDISK A/S 
      9.11.1 Overview 
      9.11.2 Primary business 
      9.11.3 Financials 
      9.11.4 Strategy 
      9.11.5 Developments 
  9.12 F. HOFFMANN-LA ROCHE LTD 
      9.12.1 Overview 
      9.12.2 Primary business 
      9.12.3 Financials 
      9.12.4 Strategy 
      9.12.5 Developments 
  9.13 TERUMO CORPORATION 
      9.13.1 Overview 
      9.13.2 Primary business 
      9.13.3 Financials 
      9.13.4 Strategy 
  9.14 YPSOMED AG 
      9.14.1 Overview 
      9.14.2 Primary business 
      9.14.3 Financials 
      9.14.4 Strategy 
      9.14.5 Developments
 
LIST OF TABLES   
     
1  BRIC: DIABETES CARE DEVICES MARKET FORECAST, BY GEOGRAPHY 2008 – 2015 ($MILLION) 
2  BRAZIL: DIABETES CARE DEVICES MARKET FORECAST, BY SEGMENTS 2008 – 2015 ($MILLION) 
3  RUSSIA: DIABETES CARE DEVICES MARKET FORECAST, BY SEGMENTS 2008 – 2015 ($MILLION) 
4  INDIA: DIABETES CARE DEVICES MARKET FORECAST, BY SEGMENTS 2008 – 2015 ($MILLION) 
5  CHINA: DIABETES CARE DEVICES MARKET FORECAST, BY SEGMENTS 2008 – 2015 ($MILLION) 
6  NEW PRODUCT LAUNCHES IN DIABETES CARE DEVICES MARKET (2006 – 2010)   
7  JOINT AGREEMENTS IN DIABETES CARE DEVICES MARKET 

LIST OF FIGURES   
     
1  BRIC: Diabetes Care Devices Market, by Segment, 2010 – 2015 ($Million) 
2  BRIC: Diabetes Care Devices Market, by Revenue, 2008 – 2015 ($Million) 
3  BRIC: Diabetes Care Devices Market, by Segments 
4  Evolution of Diabetes Management Devices 
5  Different Insulin Delivery Devices 
6  Clinical Usage of CGM 
7  BRIC: Diabetes Care Devices Market Share, by Segments 
8  Product Lifecycle for Diabetes Care Devices in BRIC 
9  CGM with FDA Approval (2010) 
10  Diabetes Care Management Solution Launch Path 
11  Expected Penetration of Diabetes Care Management Solution (DCMS) 
12  Global & BRIC Market Growth Rate 
13  BRIC: Diabetes Care Devices: Key Drivers & Restraints 
14  Distribution of Medical Assistance Expenditure 
15  Brazil: Market Share of Diabetes Care Devices 
16  Brazil: Diabetes Care Devices Market Forecast 2008 – 2015 ($Million) 
17  Brazil: Diabetes Care Devices: Key Drivers & Restraints 
18  Increasing Obesity: Brazil 
19  Brazil: Population Shift towards Urban Area 
20  Brazil: Diabetes Care Devices: Competitive Landscape (2010) 
21  Brazil: Insulin Pumps: Market Forecast 2008 – 2015 ($Million) 
22  Brazil: Insulin Pumps: Competitive Landscape (2010) 
23  Brazil: SMBG Market Forecast 2008 – 2015 ($Million) 
24  Brazil: SMBG Competitive Landscape (2010) 
25  Brazil: CGM Market Forecast 2008 – 2015 ($Million) 
26  Brazil: CGM Competitive Landscape (2010) 
27  Russia: Diabetes Care Devices Segments 
28  Russia: Diabetes Care Devices: Market Forecast, 2008 – 2015 ($Million) 
29  Russia: Diabetes Care Devices’ Key Drivers & Restraints 
30  Russia: Increasing Diabetic Population 
31  Russia: Diabetes Care Devices’ Competitive Landscape (2010) 
32  Russia: Insulin Pumps Market Forecast 2008 – 2015 ($Million) 
33  Russia: Insulin Pumps Competitive Landscape (2010) 
34  Russia: SMBG Market Forecast 2008 – 2015 ($Million) 
35  Russia: SMBG Competitive Landscape (2010) 
36  Russia: CGM Market Forecast 2008 – 2015 ($Million) 
37  Russia: CGM Low Adoption 
38  India: Diabetes Care Devices Market Forecast 2008 – 2015 ($Million) 
39  India: Diabetes Care Devices Key Drivers & Restraints 
40  World Diabetic Population: India’s Share 
41  India: Diabetes Care Devices Competitive Landscape (2010) 
42  India: Insulin Pumps Market Forecast 2008 – 2015 ($Million) 
43  India: Insulin Pumps Competitive Landscape (2010) 
44  India: SMBG Market Forecast 2008 – 2015 ($Million) 
45  India: SMBG Competitive Landscape (2010) 
46  India: CGM Market Forecast 2008 – 2015 ($Million) 
47  China: Diabetes Care Devices Market Forecast 2008 – 2015 ($Million) 
48  China: Diabetes Care Devices Key Drivers & Restraints 
49  China: Diabetes Care Competitive Landscape (2010) 
50  China: Insulin Pumps Market Forecast 2008 – 2015 ($Million) 
51  China: Insuiln Pumps Competitive Landscape (2009) 
52  China: SMBG Market Forecast 2008 – 2015 ($Million) 
53  China: SMBG Competitive Landscape (2010) 
54  China: CGM Market Forecast 2008 – 2015 ($Million) 
55  China: CGM Competitive Landscape (2010) 
56  BRIC: Diabetes Care Devices Competitive Landscape (2010)

Diabetes Care Device Market to reach $1.1 billion in 2015 at a CAGR of 17% from 2010 to 2015

This market research report analyzes the diabetes care devices market in Brazil, Russia, India, and China (BRIC) from 2010 to 2015. It studies the major market drivers and opportunities and also evaluates the major market trends in each geographic region. The report categorizes the overall BRIC market for diabetes care devices into the submarkets for insulin pumps, self-monitoring blood glucose systems, and continuous glucose monitoring systems.

BRIC: DIABETES CARE DEVICES MARKET, BY SEGMENTS


Source: MarketsandMarkets Analysis

The diabetes care devices market in BRIC nations was approximately worth $489.7 million in 2010 and is expected to witness a CAGR of 17% from 2010 to 2015. The market is witnessing significant growth due to the increasing incidence of diabetes and the corresponding rise in governmental support for diabetes care.

China was the largest market in 2010; as far as diabetes care was concerned; with approximately $216.1 million, followed by India, Brazil, and Russia. The briefings on the Diabetes Care Devices Market in BRIC (2010-2015) will benefit endocrinologists and diabetologists, diabetes associations, diabetes care devices manufacturers and vendors, as well as research and consulting firms.